Ionis Pharmaceuticals IONS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$326.98M+14.3% | -$381.39M-48.8% | -$256.34M+4.4% | -$268.22M+41.4% | -$458.03M-0.9% | ||
| $11.08M+10.7% | $10.01M+11.3% | $8.99M-1.2% | $9.1M-2.2% | $9.3M-3.3% | ||
| $147.43M+10.1% | $133.87M+5.7% | $126.7M-0.7% | $127.54M-0.8% | $128.58M-1.2% | ||
| -$910.63M-239% | -$268.58M-8.7% | -$247.01M-7.1% | -$230.57M+54.1% | -$501.78M-0.2% | ||
| $60.63M+17.9% | $51.44M-7.6% | $55.65M-6.4% | $59.44M+11.4% | $53.36M+17.9% | ||
| $88.59M+132% | -$277.78M— | —— | —— | —— | ||
| $730.9M+8.1% | $675.84M+698% | $84.66M-83.1% | $499.49M-0.3% | $500.8M-4.1% | ||
| -$90.81M-170% | $130.18M+3,385% | $3.74M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ionis Pharmaceuticals generate?
- Ionis Pharmaceuticals (IONS) generated -$910.6M in operating cash flow over the trailing twelve months.
- What is Ionis Pharmaceuticals's free cash flow?
- After $60.6M of capital expenditures, Ionis Pharmaceuticals's free cash flow was -$1.3B over the trailing twelve months, down 133.2% year over year.
- Where does Ionis Pharmaceuticals's cash flow data come from?
- Every line is extracted from Ionis Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
